Yonsei University Health System holds its Medical Science Forum Yonsei University Health System (YUHS) is focusing on Biomedical Science Merger Studies as an area of research for the next generation. The 3rd YUHS Medical Science Forum was held on November 28th at the Dental Hospital Auditorium, and was focused on Biomedical Science Merger Studies. The Forum included discussions on the present condition, as well as future plans and support for this growing field. Professor Shin Dong-Chun (Preventive Medicine) explained, "The Yonsei University College of Medicine and the Korean Institute of Science and Technology (KAIST) have formed an Engineering and Natural Sciences research team that is studying the effects of nanomatter on both the environment and human body." YUHS is distinguished internationallyin the area of proteomics, having published 55 SCI papers in the last five years. Since last year, the Yonsei Biomedical Science Program has conducted studies to form the basis of high-tech merger technology. Studies are in areas such as cardiovascular and metabolic disease and cancer treatment. YUHS also operates 6 specialized research centers supported by the Ministry of Health and Welfare's Health and Medical Technology Research Development Program. In addition, the Colleges of Medicine and Dentistry were selected for the 2nd stage of the Brain Korea 21 Project for Medical Science. People from YUHS are playing important roles in various ministries and organizations such as the Ministry of Science and Technology and the Korea Research Foundation. In particular, Yonsei's Medical and Dental Colleges are producing numerous quality research results that are playing a leading role in the nation's biomedical science merger studies. Biomedical Science Merger Studies is a program that conducts collaborative biomedical science research in the fields of medicine, life science, and engineering. The program began at Harvard University and MIT in 1977, and was followed years later by the establishment of a Life Science major at Stanford University in 2002. Cornell University, the University of San Francisco, and Purdue University also joined in the trend. In Korea, Pohang University of Science and Technology and Catholic University of Korea formed a research group that developed immune regulation treatment. In addition, KAIST, Seoul National University, and Korea University are planning to form research groupsfor biomedical merger studies.